MoveSurge

Alaunos Therapeutics finalizes its acquisition of Velaris Therapeutics, enhancing its pipeline for pulmonary arterial hypertension treatments.

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.

Share